SEC Form 4 · accession 0001645627-17-000040
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 19, 2017
Accepted (ET)
Apr 24, 2017 · 2:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.074 | A | 20,238,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0738 | A | 20,239,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0724 | A | 20,240,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0722 | A | 20,241,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0724 | A | 20,242,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0697 | A | 20,243,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0697 | A | 20,244,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0697 | A | 20,245,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0735 | A | 20,246,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.077 | A | 20,247,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.075 | A | 20,248,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0695 | A | 20,249,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.07 | A | 20,250,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.07 | A | 20,251,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.07 | A | 20,252,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.07 | A | 20,253,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.07 | A | 20,254,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0689 | A | 20,255,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0678 | A | 20,256,949 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $0.0679 | A | 20,257,949 | D | |
| Common Stock | Apr 20, 2017 | P | 1,000 | $0.06 | A | 20,258,949 | D | |
| Common Stock | Apr 20, 2017 | P | 2,000 | $0.0579 | A | 20,260,949 | D | |
| Common Stock | Apr 20, 2017 | P | 2,000 | $0.0579 | A | 20,262,949 | D | |
| Common Stock | Apr 20, 2017 | P | 1,000 | $0.0579 | A | 20,263,949 | D | |
| Common Stock | Apr 20, 2017 | P | 1,000 | $0.0579 | A | 20,264,949 | D | |
| Common Stock | Apr 20, 2017 | P | 1,000 | $0.0579 | A | 20,265,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.057 | A | 20,266,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.057 | A | 20,267,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0568 | A | 20,268,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.056 | A | 20,269,949 | D |
Table II — derivative securities
No Table II lines on this filing.